It never seems to stop. Another day, more nonsense from everyone’s favorite reverse merger pink sheet Coronacrapper, Cytodyn (CYDY). So just what is Cytodyn hyping today?
After the bell last night, on the 7th of June, the company issued the latest in a long series of breathless press releases (here) touting, this time, an animal study. Eighteen (18) rhesus macaques were given Cytodyn’s “wonder drug” leronlimab and then deliberately infected with SHIV (aka Monkey AIDS) in an intrarectal challenge (aka up the butt). And what do you know? One of the two doses studied seemed to be effective in preventing the transmission of the Monkey AIDS (hard to say for sure, as there was no control group and n=18 is too small to make valid determinations, but hey, this is CYDY, where it’s all about the press releases to keep American and German retail morons excited). Great news for macaques? Not really. Because just a year ago a study was published on a vaccine that keeps macaques safe from infection by SHIV (here).
But The Nadir won’t tell you about that, because the point of press release is to get the retail base excited about the idea of using leronlimab as “PrEP” (Pre-Exposure Prophylactic) for human AIDS. Currently the approved PrEP regimen is a well known combination pill known as Truvada. Cytodyn is trying to hype up the idea of using a weekly or bi-monthly injection of leronlimab instead. Said The Nadir:
“We are eager to build upon these preclinical results describing leronlimab’s utility in HIV prevention by initiating clinical studies for leronlimab as a PrEP treatment. Current PrEP options require a continued daily dosing regimen in order to be effective and are inherently difficult to maintain in the long-term,” said Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn. “Coupled with its safety profile, leronlimab could offer a much needed simple and long-lasting preventative treatment option for people at risk of HIV infection,” concluded Dr. Pourhassan.
It is all just warmed-over nonsense, of course, as The Nadir has been doing this since at least 2013! Remember this press release?